FibroBiologics (FBLG) Shares Issued (2022 - 2026)
FibroBiologics (FBLG) posted quarterly Shares Issued of $686244.0 for Q2 2026, down 88.43% year-over-year from $5.9 million in Q2 2025, and up 140.1% on a QoQ basis from $285812.0 in Q1 2026.
FibroBiologics (FBLG) Shares Issued (2022 - 2026) Analysis & Trends
FibroBiologics has reported Shares Issued for 5 years, with the latest figure at $686244.0 in Q2 2026.
- Shares Issued for Q2 2026 came in at $686244.0, down 88.43% year-over-year; the trailing twelve-month figure through Jun 2026 was $686244.0 (down 88.43% YoY), and the FY2025 annual result was $285801.0, down 93.74% from the prior year.
- Shares Issued improved to $686244.0 in Q2 2026, from $285812.0 in the prior quarter.
- Over five years, Shares Issued peaked at $5.9 million in Q2 2025 and troughed at $101250.0 in Q4 2022.
- A 5-year average of $3.2 million and a median of $4.0 million in 2024 frame the typical range for Shares Issued.
- The widest annual swing landed in 2023, when Shares Issued soared 3641.73%; it then tumbled 94.68% in 2026.
- A 5-year view of Shares Issued shows it stood at $101250.0 in 2022, then soared by 3641.73% to $3.8 million in 2023, then climbed by 20.5% to $4.6 million in 2024, then tumbled by 93.74% to $285801.0 in 2025, then jumped by 140.11% to $686244.0 in 2026.
- Per Business Quant data, the three most recent Shares Issued figures were $686244.0 in Q2 2026, $285812.0 in Q1 2026, and $285801.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | FibroBiologics | 8.97 Mn | 8.97 Mn | - | 686,244.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 686,244.00 |
| Jun 30, 2026 | 686,244.00 |
| Mar 31, 2026 | 285,812.00 |
| Mar 31, 2026 | 285,812.00 |
| Dec 31, 2025 | 285,812.00 |
| Dec 31, 2025 | 285,812.00 |
| Sep 30, 2025 | 2.35 Mn |
| Sep 30, 2025 | 2.35 Mn |
| Jun 30, 2025 | 2.33 Mn |
| Jun 30, 2025 | 2.33 Mn |
| Mar 31, 2025 | 5.37 Mn |
| Mar 31, 2025 | 5.37 Mn |
| Dec 31, 2024 | 4.57 Mn |
| Dec 31, 2024 | 4.57 Mn |
| Sep 30, 2024 | 4.03 Mn |
| Sep 30, 2024 | 4.03 Mn |
| Jun 30, 2024 | 4.01 Mn |
| Jun 30, 2024 | 4.01 Mn |
| Mar 31, 2024 | 4.01 Mn |
| Mar 31, 2024 | 4.01 Mn |